(Q38061184)

28 August 2017

1 reference

title

Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies (English)

1 reference

28 August 2017

1 reference

Chin-Hsiao Tseng

1

1 reference

28 August 2017

Farn-Hsuan Tseng

series ordinal

2

1 reference

28 August 2017

publication date

1 January 2012

1 reference

Journal of Environmental Science and Health, Part C: Environmental Carcinogenesis and Ecotoxicology Reviews

28 August 2017

published in

1 reference

28 August 2017

volume

30

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

368-402

1 reference

Effects of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on the urine and urothelium of the rat.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

The mechanisms of action of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Retinoid x receptor heterodimers in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Nonclinical safety evaluation of muraglitazar, a novel PPARalpha/gamma agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Pioglitazone and bladder cancer in human studies: is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Effects of PPARgamma and combined agonists on the urinary tract of rats and other species

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma Agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Urine acidification has no effect on peroxisome proliferator-activated receptor (PPAR) signaling or epidermal growth factor (EGF) expression in rat urinary bladder urothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Rodent carcinogenicity profile of the antidiabetic dual PPAR alpha and gamma agonist muraglitazar.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Urothelial carcinogenesis in the urinary bladder of rats treated with naveglitazar, a gamma-dominant PPAR alpha/gamma agonist: lack of evidence for urolithiasis as an inciting event

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Suppressive effects of acid-forming diet against the tumorigenic potential of pioglitazone hydrochloride in the urinary bladder of male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

PPARalpha agonist-induced rodent tumors: modes of action and human relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Rodent carcinogenicity of peroxisome proliferators and issues on human relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Rodent carcinogenicity with the thiazolidinedione antidiabetic agent troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Neoplastic and non-neoplastic changes in F-344 rats treated with Naveglitazar, a gamma-dominant PPAR alpha/gamma agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

PPAR trilogy from metabolism to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Activation of immediate-early gene expression by peroxisome proliferators in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

PPAR alpha and PPAR gamma coactivation rapidly induces Egr-1 in the nuclei of the dorsal and ventral urinary bladder and kidney pelvis urothelium of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Effects of sodium ascorbate, sodium saccharin and ammonium chloride on the male rat urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Cell proliferation in the bladder and implications for cancer risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Human bladder cancer: evidence for a potential irritation-induced mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Role of urinary physiology and chemistry in bladder carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Species comparison of the content and composition of urinary proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Promoter rearrangements cause species-specific hepatic regulation of the glyoxylate reductase/hydroxypyruvate reductase gene by the peroxisome proliferator-activated receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Investigations of rodent urinary bladder carcinogens: collection, processing, and evaluation of urine and bladders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Exploring In Vitro/In Vivo Correlation: Lessons Learned from Analyzing Phase I Results of the US EPA's ToxCast Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Epithelial tumours of the lower urinary tract in humans and rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Rodent bladder tumors do not always predict for humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Update on artificial sweeteners and bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Changing patterns of bladder cancer in the USA: evidence of heterogeneous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Anatomical relationships of urinary bladders compared: their potential role in the development of bladder tumours in humans and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Pioglitazone for diabetes prevention in impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Diabetic ketoacidosis in type 2 diabetes mellitus--pathophysiology and clinical presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population: the ARIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Association between metabolic syndrome and the presence of kidney stones in a screened population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

The rise and fall of rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Occurrence, efficacy, metabolism, and toxicity of triclosan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

The role of MicroRNA in chemical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Gene expression profiling as an initial approach for mechanistic studies of toxicity and tumorigenicity of herbal plants and herbal dietary supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Molecular aspects of microcystin-induced hepatotoxicity and hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Prostate cancer mortality in Taiwanese men: increasing age-standardized trend in general population and increased risk in diabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Diabetes and non-Hodgkin's lymphoma: analyses of prevalence and annual incidence in 2005 using the National Health Insurance database in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Diabetes, insulin use and Helicobacter pylori eradication: a retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10590501.2012.735519

10.1080/10590501.2012.735519

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference